SCHEMBL19960167

SCHEMBL19960167

O=P(c1ccccc1)(c1ccc(-c2ccccc2)cc1)c1ccc2nc3c4cc5ccccc5cc4c4ccccc4n3c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 5/20 0.41
HPGD P15428 5/20 0.41
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 3/20 0.36
MAPT P10636 2/20 0.36
TP53 P04637 2/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 1/20 0.36
AHR P35869 1/20 0.36
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.34
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960119 0.96 KDM4E (0.39) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL19960275 0.92 ALDH1A1 (0.38) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL19960259 0.92 ALDH1A1 (0.38) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL19959975 0.89 KDM4E (0.40) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL19928976 0.89 KDM4E (0.42) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL19960117 0.88 KDM4E (0.38) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL19959783 0.88 KDM4E (0.38) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL20276037 0.88 ALDH1A1 (0.45) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL19928981 0.88 ALDH1A1 (0.45) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL19959973 0.88 KDM4E (0.40) KDM4EALDH1A1HPGDKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885ALDH1A1 750/4885HPGD 2982/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 KDM4E 1997/4885ALDH1A1 750/4885HPGD 2982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.